Compare IVA & DAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVA | DAO |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | France | China |
| Employees | 77 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2019 |
| Metric | IVA | DAO |
|---|---|---|
| Price | $5.48 | $12.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $16.20 | N/A |
| AVG Volume (30 Days) | ★ 254.3K | 49.8K |
| Earning Date | 03-30-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.24 |
| Revenue Next Year | $751.20 | $14.60 |
| P/E Ratio | ★ N/A | $72.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.94 | $8.00 |
| 52 Week High | $7.98 | $13.04 |
| Indicator | IVA | DAO |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 62.06 |
| Support Level | $4.98 | $8.96 |
| Resistance Level | $6.42 | $12.96 |
| Average True Range (ATR) | 0.24 | 1.05 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 44.54 | 67.29 |
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.